Fortress Biotech Inc (FBIO)

Finanzdaten der Fortress Biotech Inc-Aktie (FBIO)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	34.67% 13.03	19.95	34.75	17.39	12.43
Cost Of Revenue	13.32% 6.816	6.015	6.429	7.767	6.449
Gross Profit	55.39% 6.214	13.93	28.32	9.619	5.98
Operating Expenses	27.53% 42.78	33.55	42.08	59.72	64.85
Benefits Costs and Expenses	7.21% 52.05	48.55	45.34	76.69	67.57
Costs And Expenses	25.37% 49.60	39.56	48.51	67.49	71.30
Operating Income/Loss	86.43% -36.57	-19.61	-13.76	-50.10	-58.87
Nonoperating Income/Loss	72.67% -2.457	-8.991	3.175	-9.196	3.722
Income/Loss From Continuing Operations Before Tax	36.42% -39.02	-28.61	-10.58	-59.30	-55.15
Income Tax Expense/Benefit	100.00% -	0.358	0.141	-	-
Income/Loss From Continuing Operations After Tax	34.73% -39.02	-28.96	-10.72	-59.30	-55.15
Net Income/Loss	34.64% -39.02	-28.98	-10.72	-59.30	-55.15
Preferred Stock Dividends And Other Adjustments	15.24% 2.314	2.008	2.008	2.008	-
Attributable To Noncontrolling Interest	19.80% -23.61	-19.70	-5.679	-34.52	-33.61
Basic Average Shares	1,849% 17.15	0.8799	7.4987	110.66	101.89
Basic Earnings Per Share	94.34% -1.03	-0.53	-0.94	-0.24	-0.23
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	15.24% 2.314	2.008	2.008	2.008	-